UU����ֱ��

View the related checklists about Subscription

New to role—in-house lawyers—handover—checklist

New to role—in-house lawyers—handover—checklist Where you are taking over your role from someone else and you are offered a handover, it is strongly recommended that you take the opportunity to speak to your predecessor, even if it is only a brief telephone call. This Checklist is intended for new in-house lawyers joining an organisation to replace the organisation’s previous in-house lawyer. It sets out some key areas you may want to cover in any handover with your predecessor, however short. It should be read in conjunction with Practice Note: Taking up a new role in-house—replacing a previous in-house lawyer. Nevertheless, the role is now yours and you needn’t be influenced to carry on exactly as before. There are always many ways of doing things and you must stamp your own mark on your role. You should build on what was done well previously and, where it is clear that some things weren’t working as well as they should, be prepared to act quickly to change things. You may need to...

Commercial contract review and execution (business personnel)—checklist

Commercial contract review and execution (business personnel)—checklist This is a Checklist for in-house lawyers to provide to those of its employees (eg procurement or sales professionals) who are engaged in negotiating commercial contracts. It sets out the primary issues to consider when negotiating or reviewing a business-to-business commercial contract, and includes practical guidance. This Checklist may be suitable for use in low risk contracts where employees who are not legally qualified are authorised to conduct negotiations and contract review. It may be customised as required to work with a company playbook on contract negotiation and review, to include suggested fall-back drafting positions and escalation points for recourse to a legal team as appropriate. As it is intended to be used by non-legal professionals, it does not include links to further detailed legal commentary in each case. For a Checklist intended for use by legal professionals with links to further information, see: Commercial contract drafting and review—checklist. In-house lawyers should check that business personnel engaged in negotiating and concluding commercial contracts...

View the related practice notes about Subscription

Practical steps involved in implementing growth shares

Practical steps involved in implementing growth shares What are growth shares and are they appropriate? Growth shares, also known as value shares or hurdle shares, are a special class of shares that have restricted rights. These rights are designed to allow employees only to participate in post-acquisition increases in the value of the company. For more detailed explanation of the key features of growth shares and when they are normally introduced by a company, see Practice Note: Growth shares (value shares). Key features of growth shares Growth shares are specially constituted and classified under the articles of association of the company as a separate class of shares from the existing shares in the company. They will be issued to selected employees and will be subject to the provisions of the articles of association and also either to the subscription agreement that each participating employee will be asked to sign or the option documentation that they enter into, where the employee acquires their growth shares via an option over...

Private Client Legal Research resources

Private Client Legal Research resources The following key Private Client resources are available in Lexis+® UK and linked to throughout Private Client content, providing useful practical commentary, legislation, rules and guidance for Private Client lawyers working in private practice or in-house. Please note the titles listed can only be accessed with the relevant Lexis+® UK subscription(s). Wills, probate and trusts Title Summary Who should use this resource? Williams on Wills The leading commentary on all aspects of the law of Wills. Lawyers or other professionals involved in the drafting or interpretation of Wills. Tristram and Coote's Probate Practice The leading commentary on probate, providing up-to-date, expert guidance on all aspects of probate procedure and including precedents recommended by Probate Registrars. Lawyers or other professionals involved in probate or estate administration work, including contentious probate. Butterworths Wills Probate and Administration Service A comprehensive service containing clear, step-by-step guidance on all areas of the law and practice of probate and estate administration, from...

View the related precedents about Subscription

Precedent signing and closing memorandum for a commercial mortgage-backed securities transaction

Precedent signing and closing memorandum for a commercial mortgage-backed securities transaction A Signing and Closing Memorandum is required to assist the smooth execution of a complex transaction. This precedent signing and closing memorandum sets out steps to be taken in order to close a commercial mortgage-backed securities (CMBS) transaction. Additional documents or steps may be required depending on the specific transaction. [ISSUER] [CURRENCY][AGGREGATE AMOUNT] CLASS [A] NOTES DUE [•] AND [CURRENCY] [AGGREGATE AMOUNT] CLASS [B] NOTES DUE [•] (THE NOTES) SIGNING AND CLOSING MEMORANDUM 1 Parties involved in the transaction THE PARTIES Issuer [●] Holdings [●] Originator [●] Arranger [●] Manager [●] Trustee [●] Security Trustee [●] Paying Agent [●] Account Bank [●] Cash Manager [●] Servicer [●] Special Servicer [●] Swap Counterparty [●] Liquidity Facility Provider [●] Registrar [●] Corporate Services Provider [●] [Listing Agent] [●] Listing Authority [●] Stock Exchange [●] [Rating Agencies] [●] Euroclear Euroclear Bank SA Clearstream Clearstream Banking, societe anonyme Common Depositary [●] Auditor [●] Valuer [●] Issuer's Counsel...

Draft Witness Statement—personal representative—family provision claim

Draft Witness Statement—personal representative—family provision claim This Precedent is based on a precedent found in Inheritance Act Claims: Law, Practice and Procedure Precedents by Andrew Francis (available subject to subscription). [Indorsement as to party making statement, date etc as in CPR Part 32 PD, para 17] IN THE [HIGH COURT OF JUSTICE] CLAIM NO. HC […] [CHANCERY DIVISION] [BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES] [PROPERTY TRUSTS AND PROBATE LIST] IN THE MATTER OF THE ESTATE OF [INSERT NAME] DECEASED IN THE MATTER OF THE INHERITANCE (PROVISION FOR FAMILY AND DEPENDANTS) ACT 1975 between: 1 [INSERT NAME] Claimant 2 [INSERT NAME] (the personal representative of the deceased) and 3 [INSERT NAME] Defendants WITNESS STATEMENT OF THE FIRST DEFENDANT I, [name], of [address], solicitor, WILL SAY as follows: 1 I am a solicitor of the Supreme Court and a Partner in the firm of [name] which practices at the above address.

View the related q&as about Subscription

What is a retail offer in the context of an IPO or secondary offer?

What is a retail offer in the context of an IPO or secondary offer? A retail investor is an individual investor who buys and sells shares for their own account. Retail investors typically invest in small amounts of shares and trade infrequently. A retail investor can be distinguished from an institutional investor, such as a pension fund, hedge fund or insurance company, that makes investment decisions on behalf of its individual members. Institutional investors typically trade in large tranches of shares. As the name suggests, a retail offer is an offer of shares by a company to retail investors. Most IPOs and secondary offers on the Main Market and AIM only involve an offer to institutional investors structured as a placing of shares to a limited number of professional investors. Institutional placings can be done quickly with lower associated costs than for other methods of marketing shares. One reason why a company is discouraged from pursuing a retail offer when doing a secondary fundraise is that...

View the related News about Subscription

'Vagisan' too close to 'vagisil' for EU Pharma Trade mark, court says

Law360, London: A German pharmaceutical company has failed to revive its efforts to get a trade mark for 'Vagisan' in the EU because of its likeness to rival feminine health product 'Vagisil'.

Regulatory costs claim 3.3% of insurance brokers revenue

Law360, London: Insurance brokers in the UK pay an average 3.3% of their annual revenue to cover regulatory costs, compared with only 1.9% paid by insurers, according to research published on 1 May 2025 by consultant London Economics.